Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy

Abstract

Background/Aims: the pathogenesis of sepsis-associated encephalopathy (SAE) is multifactorial, involving neurotransmitter alterations, inflammatory cytokines, oxidative damage, mitochondrial dysfunction, apoptosis, and other factors. Mitochondria are major producers of reactive oxygen species, resulting in cellular injury. Omi/HtrA2 is a proapoptotic mitochondrial serine protease involved in caspase-dependent cell death; it is translocated from mitochondria to the cytosol after an apoptotic insult. We previously found that UCF-101, a specific inhibitor of Omi/HtrA2, has neuroprotective effects on cerebral oxidative injury and cognitive impairment in septic rats. In this study, the mechanisms and molecular pathways underlying these effects were investigated. Methods: Male Sprague–Dawley rats were subjected to cecal ligation and puncture (CLP) or sham-operated laparotomy and were administered vehicle or UCF-101 (10 µmol/kg). The hippocampus was isolated for subsequent analysis. Omi/HtrA2 expression in the mitochondria or cytosol was evaluated by immunofluorescence or western blotting. Terminal deoxynucleotidyl transferase dUTP nick end labeling staining was utilized to evaluate levels of apoptosis, and western blotting was used to evaluate apoptosis-related proteins, such as cleaved caspase-3, caspase-9, and poly (ADP-ribose) polymerase (PARP). Tight junction expression was assessed by immunofluorescence and western blotting. Mitochondrial function, inflammatory cytokines, and oxidative stress were also assayed. In addition, a wet/dry method was used to evaluate brain edema and Evans blue extravasation was used to evaluate blood–brain barrier (BBB) integrity. Results: After CLP treatment, the hippocampus exhibited a mild increase in Omi/HtrA2 expression; cytosolic Omi/HtrA2 expression increased significantly, whereas mitochondrial Omi/HtrA2 expression was reduced, indicating that CLP-induced oxidative stress resulted in the translocation of Omi/HtrA2 from mitochondria to the cytosol. Hippocampal cleaved caspase-3, caspase-9, and PARP levels were significantly higher in animals treated with CLP than in sham-operated animals, while XIAP expression was lower. Treatment with UCF-101 prevented the mobilization of Omi/HtrA2 from mitochondria to the cytosol, attenuated XIAP degradation, and decreased cleaved caspase-3, caspase-9, and PARP expression as well as apoptosis. UCF-101 also reversed the decreased mitochondrial complex I, II, and III respiration and the reduced ATP caused by CLP. In addition, UCF-101 treatment resulted in a significant improvement in BBB integrity, as demonstrated by increased occludin, claudin-5, and zonula occludens 1 levels and reduced Evans blue extravasation. No significant effects of UCF-101 on brain edema were found. Inflammatory cytokines and oxidative stress were significantly higher in the CLP-treated group than in the sham-operated group. However, the inhibition of Omi/HtrA2 by UCF-101 significantly alleviated these responses. Conclusion: Our data indicated that Omi/ HtrA2 regulates a ...

Is rosuvastatin protective against sepsis associated encephalopathy? A secondary analysis of the SAILS trial

“…Also, statin drugs inhibit the prenylation of Rac and Rho proteins [36], upgrading the expression of endothelium-derived nitric oxide synthetase (eNOS). In turn, eNOS increases NO expression, maintaining endothelial cell function, attenuating BBB damage in sepsis patients [37], thereby reducing the rate of SAE among sepsis patients through an antiin ammatory pathway. However, the exact pharmacological mechanism of immunomodulation caused by statins has not clearly been demonstrated yet.…”

Inhibition of HtrA2 alleviates inflammatory response and cell apoptosis in lipopolysaccharide‑induced acute pneumonia in rats

“…Pulmonary inflammation has always been a characteristic of pneumonia ( 14 ). Although UCF-101 has been indicated to be anti-inflammatory in the pathogenesis of sepsis complications and colitis ( 8 , 9 , 15 ), the special anti-inflammatory role of UCF-101 in pneumonia remains to be elucidated. Consistent with the reported studies that UCF-101 suppressed the release of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-1β in colon tissue in colitis, UCF-101 also decreased the levels of TNF-α, IL-6, IL-1β and MCP-1 in LPS-induced pneumonia rats in the present study.…”

“…UCF-101 was found to suppress the protease activity of HtrA2 to reduce caspase-independent apoptosis ( 24 ). Wang et al ( 15 ) reported that mitochondrial HtrA2 expression is reduced in murine sepsis, together with a translocation of HtrA2 from mitochondria to the cytoplasm, while UCF-101 blocks the mobilization of HtrA2 from mitochondria to the cytoplasm, and reduces XIAP, cleaved caspase-3 and caspase-9 to alleviate sepsis-associated encephalopathy. Hu et al ( 9 ) demonstrated the neuroprotective effect of UCF-101 by inhibiting caspase activity and cell apoptosis to attenuate sepsis-induced cognitive dysfunction.…”

Senkyunolide I Protects Against Sepsis-associated Encephalopathy by Attenuating Sleep Deprivation in a Murine Model of Cecal Ligation and Puncture

“…The clinical manifestations of SAE vary greatly, from compromise in attention and orientation to delirium and even coma (5). Neuronal apoptosis, microcirculatory dysfunction and mitochondrial dysfunction has been implicated in SAE (6)(7)(8). The local production of pro-in ammatory mediators may resulting in impairment of central nervous system, and thus, microglia activation and the release of in ammatory cytokines, such as TNF-α and IL-1β, play a central role in the development of SAE (9,10).…”